Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Why so angry?
Why would they move the Ask back to 1.00 straight after a very modest Buy this morning?
Whenever the MM's are deeking about with the sp, they wheel out their snap dogs.
#tooobvious
DP64, The board I was referring to was ADVFN share chat and to be honest I don't post on there very often.
Hi gixer,
I will be interested to read your post on other board. It will be nice to know which board you are referring to.
Spot on gixer, 10K looks a buy to me
Ok great
I put an email address on the other board that you can contact me on and send your number.
Would like to speak to you by phone
Killed any buying this morning with a spread like that.
Never truer words colt . It’s a sadomasochism beyond belief and utterly depressing .
Long term strategic co-operation framework agreement aside.
This is probably the best publicity Provexis and Fruitflow have had in China.
https://www.baidu.com/s?wd=%22%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%22%20%22fruitflow%22%20%22%E8%BD%BB%E7%BB%9C%E7%B4%A0%22&pn=0&oq=%22%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%22%20%22fruitflow%22%20%22%E8%BD%BB%E7%BB%9C%E7%B4%A0%22&ie=utf-8&rsv_pq=a2f20e590007c4d8&rsv_t=482fJxzdEcgY4%2BOKpW4BGUnYH8LGZNISDZyAbE3RvAUuTQBc9SlH98I9AwU&gpc=stf%3D1633515099%2C1636193499%7Cstftype%3D1&tfflag=1&bs=%22%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%22%20%22fruitflow%22%20%22%E8%BD%BB%E7%BB%9C%E7%B4%A0%22&rsv_jmp=fail
https://www.google.co.uk/search?q=%22%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%22+%22fruitflow%22&tbas=0&tbs=qdr:w&sxsrf=AOaemvI5xxZiZVCF8WS0cj0QGJSj5KUqmg:1636193421492&ei=jVSGYe24HdXD8gLM1LOQCw&start=0&sa=N&ved=2ahUKEwits6-9v4P0AhXVoVwKHUzqDLI4HhDy0wN6BAgBEDs&biw=1366&bih=625&dpr=1
Guangzhou is smog central in China. An ideal p-lace to launch a product aimed at dealing with the effects of air pollution. I recall thinking "what the hell am I breathing" when I visited it some years ago.
"Focusing on consumer health, the company has continued to try to expand into new business
segments. In 2020, the company has tried to deploy over-the-counter drugs (OTC) business and
functional food business which are still in the incubation period. In the massive health industry
ecosystem centered on VDS, extending upward to OTC, and downward to functional foods, the
company continued to build and enrich the brand matrix in different business segments, and forming a
good complementarity among brand positioning, consumer groups and needs, and constantly
consolidated brand power to create value for consumers' health."
"17. Establishment of Guangzhou Hurui Pharmaceutical Technology Development Co,. Ltd
On August 20, 2020,Guangzhou Hurui Pharmaceutical Investment Co,. Ltdset up a new wholly-owned subsidiary, Guangzhou Hurui Pharmaceutical Technology Development Co,. Ltd, with a registered capital of RMB 10 million and
the executive director of LIN Zhicheng. This company is mainly used for holding OTC approval and outsourced
processing"
https://upload-yyj.by-health.com/upload/files/0324160545898_2020%20Annual%20Report%20(Compact%20Edition).pdf
Have to admire your tenacity and pluck. This is a share held by optimists many of whom will be old and worn out by the time the company turns a profit of more than the average corner shop. It has all been a waste of time from a financial point of view and the pent up desire to exit asap will be overwhelming as soon as the SP gets to more than a penny or so. No so blind etc but a super product all the same. Bottom drawer until 2024/2025 at least! All in my own opinion of course.
PS Any reason the good doctor wasn't able to attend?
Guangdong Haojia Pharmaceutical Co., Ltd. Is another.
I believe By-health still own Guangdong Baiteng Pharmaceutical Ltd but to be honest I have no idea what they do.
Good question though, I will need to look into By-Healths other subsidiaries.
gix
have BH forayed away from nutrition to drug development before ?
WS
"(2) on drug research and development
within the term of the Agreement, Provexis and companies to cooperate, the public pharmaceutical R & D projects in accordance with the terms of this agreement
have the Secretary in agreement in the exclusive development rights for the drug."
https://cfi.cn/p20211105000806.html
PDF
http://www.cninfo.com.cn/new/disclosure/detail?plate=szse&orgId=9900015867&stockCode=300146&announcementId=1211508284&announcementTime=2021-11-05%2007:49
Snippets
https://www.finet.hk/newscenter/news_content/6184e408661e09b134412e08
https://www.gelonghui.com/live/588699
http://www.nbd.com.cn/articles/2021-11-05/1982431.html
https://cfi.cn/p20211105000806.html
https://www.jwview.com/jingwei/html/11-05/440617.shtml
http://xinpi.stcn.com/finalpage/2021-11/05/pdf1211508284.shtml
https://news.sina.com.tw/article/20211105/40490906.html
http://sc.stock.cnfol.com/ggzixun/20211105/29243497.shtml
etc etc.
Think you get the idea :)
http://data.eastmoney.com/notices/detail/300146/AN202111051527225504.html
Was a great day yesterday in the big smoke. Good attendance at the AGM and there was some old and some new faces. IF and DB were of course very happy and why not after the RNS not long before the AGM. Seems 2023 will be a bumper year thought IF and DS were never going to give any more info away. I will be adding more if it slips back to the early 0.8s or 0.7s. Lets see what DSM come up with.
"Provexis and By-Health will seek to collaborate on research and development projects which may result in the development and approval of Fruitflow as a drug, for potential sale and distribution in the Territories."
Was this recent study that was published in "Pharmacology" a hint to what might be coming.
https://www.frontiersin.org/articles/10.3389/fphar.2021.746107/full?utm_source=F-NTF&utm_medium=EMLX&utm_campaign=PRD_FEOPS_20170000_ARTICLE
Great news today but how will DSM react to this I wonder.
We have just pulled Fruitflows (potentially) biggest customer from under there noses.
Indena SAS in France and Italy are/were the third party manufacturer for Fruitflow II & I and I see no reason atm why this would change but I am sure there are other manufacturers out their that could easily step in.
Yeah, it was just a discussion point, not an argument.
Fully agree about volume, the more folks who are on a daily Fruitflow tab, the more valuable the company becomes. The results of the By Health studies to date re-affirms the efficacy, this new publicity can only help other brands take notice.
I not that IF's fiecest critic has been absent today, perhaps still searching for the other half of his wits.
alf
for some reason I I thought we turned a small profit with the MM Sirco using a plant in Ireland. Could be wrong.
My point I was trying to make is 1 million doses at 0.5p profit is much better than 3K doses at 5p profit. Taking DSM out of the equation helps big time for China. Whether we stick with DSM for other territories remains to be seen, but IF has just put us in a very strong negotiating position.
W?